Physician profile
Michael D Sims
NPI 1336114313
$13,767.97
in general payments reported to CMS, 2019-2025
53 companies · $2,221 in 2025
The $2,221 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,721 · 2020: $609 · 2021: $1,432 · 2022: $3,836 · 2023: $2,180 · 2024: $1,770 · 2025: $2,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,170.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,604.39 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $1,434.70 | 2022 | |
| Abbvie INC. | $1,318.96 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $1,093.93 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $966.43 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $923.76 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $830.99 | 2019-2025 | Jardiance |
| Pfizer INC. | $733.24 | 2019-2025 | |
| Abbott Laboratories | $688.76 | 2021-2025 | Freestyle Libre, Jot Dx |
| Bayer Healthcare Pharmaceuticals INC. | $359.81 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $332.35 | 2019-2025 | Belsomra, Segluromet, Steglatro |
| Amarin Pharma, INC. | $319.20 | 2019-2022 | |
| Astellas Pharma US INC | $295.35 | 2019-2025 | Veozah |
| Amgen INC. | $279.61 | 2019-2025 | Evenity, Repatha, Otezla |
| Allergan, INC. | $265.27 | 2019-2020 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.